(−)-cis-3-[2-Hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol
GPTKB entity
Statements (17)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
|
gptkbp:CASNumber |
79678-22-8
|
gptkbp:developedBy |
gptkb:Pfizer
|
gptkbp:drugClass |
cannabinoid receptor agonist
|
gptkbp:hasActivity |
CB1 receptor agonist
CB2 receptor agonist |
gptkbp:hasInChIKey |
YQEZLKZALYSWHR-UHFFFAOYSA-N
|
gptkbp:hasMolecularFormula |
C22H36O3
|
gptkbp:hasSMILES |
CCCCCCC(C)(C)C1=CC(=C(C=C1)C2CCC(CC2)CCCO)O
|
https://www.w3.org/2000/01/rdf-schema#label |
(−)-cis-3-[2-Hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol
|
gptkbp:IUPACName |
gptkb:(−)-cis-3-[2-Hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol
|
gptkbp:legalStatus |
controlled substance in some countries
|
gptkbp:otherName |
gptkb:CP_55,940
|
gptkbp:PubChem_CID |
3083548
|
gptkbp:synonym |
CP-55940
|
gptkbp:bfsParent |
gptkb:CP_55,940
|
gptkbp:bfsLayer |
8
|